Rabbit Polyclonal KIF3C antibody. Suitable for WB, IHC-P, ICC/IF and reacts with Human samples. Cited in 3 publications. Immunogen corresponding to Recombinant Fragment Protein within Human Kinesin-like protein KIF3C aa 150-300.
대체 명칭 보기
Kinesin-like protein KIF3C, KIF3C
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-KIF3C antibody (AB236748)
Paraffin-embedded human glioma tissue stained for KIF3C using ab236748 at 1/600 dilution in immunohistochemical analysis.
After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a biotinylated secondary antibody and visualized using an HRP conjugated SP system.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-KIF3C antibody (AB236748)
4% formaldehyde-fixed, 0.2% Triton X-100 permeabilized A549 (human lung carcinoma cell line) cells labeling KIF3C (green) using ab236748 at 1/200 dilution in ICC/IFF, follwed by Alexa Fluor 488-congugated Goat Anti-Rabbit IgG (H+L) secondary antibody. Counterstained with DAPI (blue).
Reactivity 정보
특성 및 보관 정보
제형
Purification 테크닉
Purification 관련 사항
보관 버퍼
배송 시 보관 조건
적절한 단기 보관 기간
적절한 단기 보관 조건
적절한 장기 보관 조건
분주 정보
보관 정보
제품 프로토콜
- Visit the General protocols
- Visit the Troubleshooting
타겟 정보
제품이 사용된 논문 (3)
Recent publications for all applications. Explore the 전체 목록 and refine your search
Frontiers in immunology 15:1420847 PubMed38975339
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of experimental & clinical cancer research : CR 43:68 PubMed38439082
2024
Applications
Unspecified application
Species
Unspecified reactive species
Bioengineered 12:3077-3088 PubMed34193018
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com